Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Plant sterols + policosanols** is a *combination dietary supplement* that contains both **plant sterols** (phytosterols) and **policosanols**. Plant sterols are plant-derived compounds structurally similar to cholesterol; they act primarily by reducing intestinal absorption of cholesterol, thus lowering LDL cholesterol levels[2][4][7]. Policosanols are a mixture of long-chain aliphatic alcohols, typically derived from sugar cane or other plant sources, and are thought to reduce cholesterol synthesis in the liver, increase the breakdown of LDL cholesterol, and reduce platelet aggregation[3][5][6]. Both components are primarily marketed for *cardiovascular risk reduction and lipid management*, especially in hypercholesterolemia and prevention of coronary heart disease[1][2][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on plant sterols + policosanols.